The third phase human trials of Bharat Biotech's COVID-19 vaccine candidate started in West Bengal and Karnataka on Wednesday. West Bengal Governor Jagdeep Dhankar inaugurated the trials at ICMR-NICED in Kolkata. Karnataka CM Yediyurappa inaugurated trials at the Vydehi Institute of Medical Sciences and Research Centre in Bengaluru.
Mumbai (Maharashtra) [India], December 2 (ANI): Maharashtra Bharatiya Janata Party (BJP) leaders are doing politics over 'Azaan' (Islamic call to prayer) instead they should focus on unemployment and GDP, said Shiv Sena leader Sanjar Raut on Wednesday.
Ahmedabad (Gujarat) [India], December 2 (ANI): The Gujarat High Court on Wednesday ordered compulsory community service at COVID-19 care centres for those who do not wear masks, which according to experts is necessary to prevent the spread of the virus.
Multan [Pakistan], December 2 (ANI): Acting against the organisers of the Pakistan Democratic Movement (PDM), an 11-party alliance, which held a rally on November 30, the Imran Khan government has filed cases against three sons of former prime minister Yousaf Raza Gillani citing violation of coronavirus SOPs and vandalism of government property.
According to the IOL website, non-subsidised prices of Indane in Metros per 14.2 kg cylinder has been kept at 594 in Delhi, Rs 620 in Kolkata, Rs 594 in Mumbai and Rs 610 in Chennai. The price of commercial LPG Cylinder, on the other hand, has seen an increase.
The US pharmaceutical giant Pfizer in collaboration with German biotech company BioNTech developed the potential COVID-19 vaccine by the name 'BNT162b2'. The vaccine has been largely successful in its clinical trials and showed 95% efficacy in its final trials. The vaccine is based on mRNA- a molecule which instructs the cell on what to code.
Berlin [Germany], December 2 (ANI/Xinhua): Germany has reported 17,270 new cases of COVID-19 over the past 24 hours, bringing the nation's total to 1,084,743, the federal Robert Koch Institute (RKI) said on Wednesday.
Washington [US], December 2 (ANI): The United Kingdom on Wednesday became the first country in the world to authorise use of Pfizer and BioNTech for emergency purpose, thus, paving way for the delivery of the vaccines from next week.
With the rollout permit issued by the UK, the country would become first in the world to begin mass vaccination. In select-nations, the experimental vaccines have so far been administered only on healthcare and other frontline workers.